Drug intelligence / Profile preview

Dansi lotion

Development stage: Unknown
Lead developer: The Second Affiliated Hospital of Hunan University of Chinese Medicine
Administration: Topical

Overview

Dansi lotion is a topical Traditional Chinese Medicine (TCM) formulation developed by The Second Affiliated Hospital of Hunan University of Chinese Medicine. It is specifically designed for the treatment of androgenic alopecia (AGA) in patients presenting with the "dampness-heat steaming" syndrome according to TCM diagnostics. The formulation is intended to address the underlying pathological factors of AGA, such as scalp inflammation and excess sebum production, which are often associated with the dampness-heat pattern. In clinical evaluation, it has been compared against 2% ketoconazole lotion to assess its efficacy in improving hair density and reducing symptoms like scalp oiliness and itching.

Brand names: Dansi lotion
Other names: Dansi Lotion

Beyond the preview

Go deeper on Dansi lotion.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dansi lotion.

Explore the full profile